Critical Examination of MED/DEV 2.12/2 Rev 2 On Post-Market Clinical Follow-Up Studies
Abstract:In this article, Haroon Atchia, CEO & Technical Director of Quality First International provides a critical examination of the European Commission's update of MEDDEV 2.12/2 entitled Post Market Clinical Follow-Up Studies, a guide for Manufacturers and Notified Bodies, published in January 2012.
Click here to download the file
Compliance Trainings
Pregnancy in the Workplace: Strategies to Protect Your Organization from Pregnancy Discrimination Claims
By - Christopher W. Olmsted
On Demand Access Anytime
By - Christopher W. Olmsted
On Demand Access Anytime
How to Vet an IRB: Expose and Fix Problems Before They Threaten Your Trial
By - Madhavi Diwanji
On Demand Access Anytime
By - Madhavi Diwanji
On Demand Access Anytime
Compliance Standards
You Recently Viewed
